Condition
Germline Mutation clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Germline Mutation clinical trials that are recruiting, at sites in 2 countries (most in United States (1), Italy (1)). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Inherited risk factors for myeloproliferative neoplasms
This project will test whether inherited (germline) genetic changes raise the risk of myeloproliferative neoplasms in people diagnosed before age 27 or with multiple affected relatives.
-
Individuals and families with DDX41 or similar inherited blood cancer risk variants
We will follow people and their family members who have DDX41 or other inherited blood cancer risk variants to see how often and when they develop MDS or AML and related health changes.
Related topics
Quick answers
How many Germline Mutation clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (1 trial), Italy (1 trial). Each study page lists its sites and which ones are recruiting.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.